OptimizeRx Sets Third Quarter 2026 Conference Call for November 11, 2026 at 4:30 p.m. ETGlobeNewsWire • 11h
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPathGlobeNewsWire • 09/22/26
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience IntelligenceGlobeNewsWire • 09/14/26
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth ConferenceGlobeNewsWire • 09/08/26
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company AdvisorGlobeNewsWire • 09/02/26
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of GrowthGlobeNewsWire • 08/12/26
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 GuidanceGlobeNewsWire • 08/12/26
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ETGlobeNewsWire • 07/29/26
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing OfficerGlobeNewsWire • 07/23/26
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing IntentGlobeNewsWire • 06/30/26
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning PlatformsGlobeNewsWire • 06/25/26
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?Zacks Investment Research • 05/28/26
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx's Authenticated EHR NetworkGlobeNewsWire • 05/21/26
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?Zacks Investment Research • 05/20/26
OPRX Boosts DSP Revenue Potential While Navigating Near-Term HeadwindsZacks Investment Research • 05/20/26
OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/12/26